Analysis of Pre and Post Covid Performance of Selected Pharmaceutical and Information Technology Stocks In Indian Market

Abstract

The COVID-19 pandemic's disruptive influence extended far beyond the realm of public health, creating a global economic crisis. Stock markets worldwide experienced significant volatility, and India was no exception. This study delves into the specific effects of the pandemic on two crucial sectors of the Indian economy: Information Technology (IT) and Pharmaceuticals. Prior to the pandemic, the Indian IT industry enjoyed a period of sustained growth. The nation established itself as a global hub for IT services, fueled by a skilled workforce, cost competitiveness, and a thriving digital infrastructure. Pharmaceutical companies, on the other hand, played a vital role in the domestic and international supply chains of essential medications. However, the sector also faced challenges, including patent expiries and increasing competition